BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11709476)

  • 1. Imaging appearances of metastases from neuroendocrine tumours of the pancreas.
    Debray MP; Geoffroy O; Laissy JP; Lebtahi R; Silbermann-Hoffman O; Henry-Feugeas MC; Cadiot G; Mignon M; Schouman-Claeys E
    Br J Radiol; 2001 Nov; 74(887):1065-70. PubMed ID: 11709476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
    Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
    Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Imaging of endocrine tumors of the pancreas].
    Thérasse E; Taillefer R
    Ann Endocrinol (Paris); 1995; 56(5):509-10. PubMed ID: 8597493
    [No Abstract]   [Full Text] [Related]  

  • 4. Pancreatic neuroendocrine neoplasms: diagnosis and management.
    Balachandran A; Tamm EP; Bhosale PR; Patnana M; Vikram R; Fleming JB; Katz MH; Charnsangavej C
    Abdom Imaging; 2013 Apr; 38(2):342-57. PubMed ID: 22707246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin receptor scintigraphy in gastrinomas.
    Jensen RT; Gibril F
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S179-85. PubMed ID: 10604126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Imaging of neuroendocrine tumors].
    Gualdi GF; Casciani E; Polettini E
    Clin Ter; 2001; 152(2):107-21. PubMed ID: 11441522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone metastases in patients with gastrinomas: a prospective study of bone scanning, somatostatin receptor scanning, and magnetic resonance image in their detection, frequency, location, and effect of their detection on management.
    Gibril F; Doppman JL; Reynolds JC; Chen CC; Sutliff VE; Yu F; Serrano J; Venzon DJ; Jensen RT
    J Clin Oncol; 1998 Mar; 16(3):1040-53. PubMed ID: 9508189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Somatostatin receptor scintigraphy and endoscopic ultrasound for the diagnosis of insulinoma and gastrinoma].
    Zimmer T; Stölzel U; Liehr RM; Bäder M; Fett U; Hamm B; Wiedenmann B; Riecken EO
    Dtsch Med Wochenschr; 1995 Jan; 120(4):87-93. PubMed ID: 7835241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of pancreatic neoplasms.
    Balachandran A; Bhosale PR; Charnsangavej C; Tamm EP
    Surg Oncol Clin N Am; 2014 Oct; 23(4):751-88. PubMed ID: 25246049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiological and nuclear medicine imaging of gastroenteropancreatic neuroendocrine tumours.
    Sundin A
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):803-18. PubMed ID: 23582920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishing small hepatic hemangiomas from vascular liver metastases in gastrinoma: use of a somatostatin-receptor scintigraphic agent.
    Termanini B; Gibril F; Doppman JL; Reynolds JC; Stewart CA; Sutliff VE; Venzon DJ; Jensen RT
    Radiology; 1997 Jan; 202(1):151-8. PubMed ID: 8988205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic neuroendocrine tumours.
    Alexakis N; Neoptolemos JP
    Best Pract Res Clin Gastroenterol; 2008; 22(1):183-205. PubMed ID: 18206821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI of pancreatic neuroendocrine tumours.
    Owen NJ; Sohaib SA; Peppercorn PD; Monson JP; Grossman AB; Besser GM; Reznek RH
    Br J Radiol; 2001 Oct; 74(886):968-73. PubMed ID: 11675319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional assessment in the multimodality imaging of pancreatic neuro-endocrine tumours.
    Bhate K; Mok WY; Tran K; Khan S; Al-Nahhas A
    Minerva Endocrinol; 2010 Mar; 35(1):17-25. PubMed ID: 20386524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endocrine tumors of the pancreas].
    Lozano-Salazar RR; Herrera MF; Hernández-Ortiz J; Campuzano M
    Rev Gastroenterol Mex; 1997; 62(3):212-7. PubMed ID: 9480529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular pancreatic lesions: spectrum of imaging findings of malignant masses and mimics with pathologic correlation.
    Bhosale PR; Menias CO; Balachandran A; Tamm EP; Charnsangavej C; Francis IR; Elsayes KM
    Abdom Imaging; 2013 Aug; 38(4):802-17. PubMed ID: 22968429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of somatostatin-receptor scintigraphy in newly diagnosed endocrine gastroenteropancreatic tumors.
    Kisker O; Bartsch D; Weinel RJ; Joseph K; Welcke UH; Zaraca F; Rothmund M
    J Am Coll Surg; 1997 May; 184(5):487-92. PubMed ID: 9145069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The surgical and systemic management of neuroendocrine tumors of the pancreas.
    Abood GJ; Go A; Malhotra D; Shoup M
    Surg Clin North Am; 2009 Feb; 89(1):249-66, x. PubMed ID: 19186239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroendocrine tumors of the pancreas].
    Gorgone A; Calbo L; Melita G; Riso F; Tigano D; Barbuscia M
    Chir Ital; 1999; 51(4):309-12. PubMed ID: 10633841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multimodal imaging of pancreatic neuroendocrine tumors].
    Müssig K; Bares R; Dudziak K; Horger M
    Rofo; 2008 May; 180(5):373-9. PubMed ID: 18464198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.